189 related articles for article (PubMed ID: 27051236)
1. Angiotensin II Modulates p130Cas of Podocytes by the Suppression of AMP-Activated Protein Kinase.
Ha TS; Park HY; Seong SB; Ahn HY
J Korean Med Sci; 2016 Apr; 31(4):535-41. PubMed ID: 27051236
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II suppresses adenosine monophosphate-activated protein kinase of podocytes via angiotensin II type 1 receptor and mitogen-activated protein kinase signaling.
Choi JY; Ha TS; Park HY; Ahn HY
Clin Exp Nephrol; 2013 Feb; 17(1):16-23. PubMed ID: 22714800
[TBL] [Abstract][Full Text] [Related]
3. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation.
Nagata D; Takeda R; Sata M; Satonaka H; Suzuki E; Nagano T; Hirata Y
Circulation; 2004 Jul; 110(4):444-51. PubMed ID: 15262850
[TBL] [Abstract][Full Text] [Related]
4. CD2-associated protein/phosphoinositide 3-kinase signaling has a preventive role in angiotensin II-induced podocyte apoptosis.
Park HY; Seong SB; Min SY; Ha TS
Int J Biochem Cell Biol; 2016 Oct; 79():370-381. PubMed ID: 27590856
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II induces nephrin dephosphorylation and podocyte injury: role of caveolin-1.
Ren Z; Liang W; Chen C; Yang H; Singhal PC; Ding G
Cell Signal; 2012 Feb; 24(2):443-450. PubMed ID: 21982880
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rg1 inhibits angiotensin II-induced podocyte autophagy via AMPK/mTOR/PI3K pathway.
Mao N; Tan RZ; Wang SQ; Wei C; Shi XL; Fan JM; Wang L
Cell Biol Int; 2016 Aug; 40(8):917-25. PubMed ID: 27296076
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II upregulates protein phosphatase 2Cα and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wasting.
Tabony AM; Yoshida T; Galvez S; Higashi Y; Sukhanov S; Chandrasekar B; Mitch WE; Delafontaine P
Hypertension; 2011 Oct; 58(4):643-9. PubMed ID: 21844485
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes.
Kang YS; Park YG; Kim BK; Han SY; Jee YH; Han KH; Lee MH; Song HK; Cha DR; Kang SW; Han DS
J Mol Endocrinol; 2006 Apr; 36(2):377-88. PubMed ID: 16595708
[TBL] [Abstract][Full Text] [Related]
9. Activation of AMP-activated protein kinase enhances angiotensin ii-induced proliferation in cardiac fibroblasts.
Hattori Y; Akimoto K; Nishikimi T; Matsuoka H; Kasai K
Hypertension; 2006 Feb; 47(2):265-70. PubMed ID: 16380538
[TBL] [Abstract][Full Text] [Related]
10. c-Abl mediates angiotensin II-induced apoptosis in podocytes.
Chen X; Ren Z; Liang W; Zha D; Liu Y; Chen C; Singhal PC; Ding G
J Mol Histol; 2013 Oct; 44(5):597-608. PubMed ID: 23515840
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II-induced podocyte apoptosis is mediated by endoplasmic reticulum stress/PKC-δ/p38 MAPK pathway activation and trough increased Na
Cardoso VG; Gonçalves GL; Costa-Pessoa JM; Thieme K; Lins BB; Casare FAM; de Ponte MC; Camara NOS; Oliveira-Souza M
BMC Nephrol; 2018 Jul; 19(1):179. PubMed ID: 30005635
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II induces endoplasmic reticulum stress in podocyte, which would be further augmented by PI3-kinase inhibition.
Ha TS; Park HY; Seong SB; Ahn HY
Clin Hypertens; 2015; 21():13. PubMed ID: 26893923
[TBL] [Abstract][Full Text] [Related]
13. 5'-AMP-activated protein kinase attenuates adriamycin-induced oxidative podocyte injury through thioredoxin-mediated suppression of the apoptosis signal-regulating kinase 1-P38 signaling pathway.
Gao K; Chi Y; Sun W; Takeda M; Yao J
Mol Pharmacol; 2014 Mar; 85(3):460-71. PubMed ID: 24378334
[TBL] [Abstract][Full Text] [Related]
14. Critical roles of PI3K/Akt/NF‑κB survival axis in angiotensin II‑induced podocyte injury.
Wang J; Fu D; Senouthai S; You Y
Mol Med Rep; 2019 Dec; 20(6):5134-5144. PubMed ID: 31638199
[TBL] [Abstract][Full Text] [Related]
15. Autophagy Precedes Apoptosis in Angiotensin II-Induced Podocyte Injury.
Seong SB; Ha DS; Min SY; Ha TS
Cell Physiol Biochem; 2019; 53(5):747-759. PubMed ID: 31622062
[TBL] [Abstract][Full Text] [Related]
16. Changes of podocyte p130Cas in diabetic conditions.
Ha TS; Choi JY; Park HY; Han GD
J Nephrol; 2013; 26(5):870-6. PubMed ID: 23559070
[TBL] [Abstract][Full Text] [Related]
17. AICAR induces cyclooxygenase-2 expression through AMP-activated protein kinase-transforming growth factor-beta-activated kinase 1-p38 mitogen-activated protein kinase signaling pathway.
Chang MY; Ho FM; Wang JS; Kang HC; Chang Y; Ye ZX; Lin WW
Biochem Pharmacol; 2010 Oct; 80(8):1210-20. PubMed ID: 20615388
[TBL] [Abstract][Full Text] [Related]
18. AICAR and Metformin Exert AMPK-dependent Effects on INS-1E Pancreatic β-cell Apoptosis via Differential Downstream Mechanisms.
Dai YL; Huang SL; Leng Y
Int J Biol Sci; 2015; 11(11):1272-80. PubMed ID: 26435693
[TBL] [Abstract][Full Text] [Related]
19. Losartan treating podocyte injury induced by Ang II via downregulation of TRPC6 in podocytes.
Chi-Xianggeng ; Hu-Bo ; Yu SY; Yin-Lianghong ; Meng-Yu ; Wang-Boxun ; Yang-Jinsheng ; Lin-Jiahui ; Huang-Dexu ; Chen-Lanlan
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1118-24. PubMed ID: 25795457
[TBL] [Abstract][Full Text] [Related]
20. CCL5 upregulates activation of AMP-activated protein kinases in vascular smooth muscle cells of spontaneously hypertensive rats.
Kim HY; Cha HJ; Kim HS
Cytokine; 2014 Jun; 67(2):77-84. PubMed ID: 24656927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
